Ensysce Biosciences Stock Analysis

Ensysce Stock Analysis Notes

About 22.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.4. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ensysce Biosciences recorded a loss per share of 1.94. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 31st of March 2023. Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614 PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse and PF26810, an extended-release prodrug of methadone for opioid use disorder. Ensysce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people. To learn more about Ensysce Biosciences call Lynn Kirkpatrick at 858 263 4196 or check out https://www.ensysce.com.

Ensysce Biosciences Investment Alerts

Ensysce Biosciences Upcoming and Recent Events

Ensysce Largest EPS Surprises

View All Earnings Estimates

Ensysce Biosciences Thematic Classifications

Ensysce Stock Institutional Investors

Note, although Ensysce Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ensysce Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.81 M.

Ensysce Profitablity

Management Efficiency

Ensysce Biosciences has return on total asset (ROA) of (1.3194) % which means that it has lost $1.3194 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.2789) %, meaning that it created substantial loss on money invested by shareholders. Ensysce Biosciences' management efficiency ratios could be used to measure how well Ensysce Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 34.52, whereas Return On Tangible Assets are forecasted to decline to (4.11). At present, Ensysce Biosciences' Other Current Assets are projected to increase significantly based on the last few years of reporting.

Technical Drivers

As of the 1st of December, Ensysce Biosciences shows the Downside Deviation of 12.3, coefficient of variation of 1743.12, and Mean Deviation of 10.82. Ensysce Biosciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Ensysce Biosciences Price Movement Analysis

Ensysce Biosciences Insider Trading Activities

Ensysce Biosciences Outstanding Bonds

Ensysce Biosciences Predictive Daily Indicators

Ensysce Biosciences Forecast Models

Ensysce Biosciences' time-series forecasting models are one of many Ensysce Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ensysce Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ensysce Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ensysce shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ensysce Biosciences. By using and applying Ensysce Stock analysis, traders can create a robust methodology for identifying Ensysce entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ensysce analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ensysce analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ensysce Biosciences stock analysis indicators help investors evaluate how Ensysce Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ensysce Biosciences shares will generate the highest return on investment. By understating and applying Ensysce Biosciences stock analysis, traders can identify Ensysce Biosciences position entry and exit signals to maximize returns.

When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.